Recombinant bovine and porcine somatotropin: Safety and benefits of these biotechnologies

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This article reviews the literature about the safety and benefits of two recombinantly derived proteins, bovine somatotropin (bST) and porcine somatotropin (pST), that likely will be used in animal agriculture in the future. When administered to dairy cows, bST increase milk production per cow approximately 15% to 20% and improves productive efficiency approximately 10%. Administration of pST to growing pigs reduces carcass fat content by as much as 70% to 80% and improves productive efficiency 15% to 35%. Because meat is a major source of total fat and saturated fatty acids in the diets of human beings, pST will allow consumers to include leaner, more nutrient-dense pork in their diets and still meet current dietary guidelines. Although these biotechnologies have not yet received regulatory approval from the Food and Drug Administration (FDA) for commercial use, information published by the FDA, the National Institutes of Health, the US Congress Office of Technology Assessment, and the American Academy of Pediatrics, as well as an extensive body of scientific evidence, indicate that these products are safe for the consumer. Nonetheless, it is important that consumers understand the benefits and safety of these biotechnologies. Dietitians can play an important role in providing information to consumers about the safety and benefits of bST and pST.

Original languageEnglish (US)
Pages (from-to)177-180
Number of pages4
JournalJournal of the American Dietetic Association
Volume93
Issue number2
DOIs
StatePublished - Feb 1993

Fingerprint

Biotechnology
biotechnology
somatotropin
Swine
Growth Hormone
Safety
swine
cattle
United States Food and Drug Administration
Fats
Diet
Nutrition Policy
Biomedical Technology Assessment
Nutritionists
National Institutes of Health (U.S.)
Agriculture
National Institutes of Health
Meat
pig carcasses
Dietary Guidelines

All Science Journal Classification (ASJC) codes

  • Food Science
  • Nutrition and Dietetics

Cite this

@article{ed3b3b47de594004acc874d09b7aa780,
title = "Recombinant bovine and porcine somatotropin: Safety and benefits of these biotechnologies",
abstract = "This article reviews the literature about the safety and benefits of two recombinantly derived proteins, bovine somatotropin (bST) and porcine somatotropin (pST), that likely will be used in animal agriculture in the future. When administered to dairy cows, bST increase milk production per cow approximately 15{\%} to 20{\%} and improves productive efficiency approximately 10{\%}. Administration of pST to growing pigs reduces carcass fat content by as much as 70{\%} to 80{\%} and improves productive efficiency 15{\%} to 35{\%}. Because meat is a major source of total fat and saturated fatty acids in the diets of human beings, pST will allow consumers to include leaner, more nutrient-dense pork in their diets and still meet current dietary guidelines. Although these biotechnologies have not yet received regulatory approval from the Food and Drug Administration (FDA) for commercial use, information published by the FDA, the National Institutes of Health, the US Congress Office of Technology Assessment, and the American Academy of Pediatrics, as well as an extensive body of scientific evidence, indicate that these products are safe for the consumer. Nonetheless, it is important that consumers understand the benefits and safety of these biotechnologies. Dietitians can play an important role in providing information to consumers about the safety and benefits of bST and pST.",
author = "Etherton, {T. D.} and Kris-Etherton, {P. M.} and Mills, {E. W.}",
year = "1993",
month = "2",
doi = "10.1016/0002-8223(93)90835-9",
language = "English (US)",
volume = "93",
pages = "177--180",
journal = "Journal of the Academy of Nutrition and Dietetics",
issn = "2212-2672",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Recombinant bovine and porcine somatotropin

T2 - Safety and benefits of these biotechnologies

AU - Etherton, T. D.

AU - Kris-Etherton, P. M.

AU - Mills, E. W.

PY - 1993/2

Y1 - 1993/2

N2 - This article reviews the literature about the safety and benefits of two recombinantly derived proteins, bovine somatotropin (bST) and porcine somatotropin (pST), that likely will be used in animal agriculture in the future. When administered to dairy cows, bST increase milk production per cow approximately 15% to 20% and improves productive efficiency approximately 10%. Administration of pST to growing pigs reduces carcass fat content by as much as 70% to 80% and improves productive efficiency 15% to 35%. Because meat is a major source of total fat and saturated fatty acids in the diets of human beings, pST will allow consumers to include leaner, more nutrient-dense pork in their diets and still meet current dietary guidelines. Although these biotechnologies have not yet received regulatory approval from the Food and Drug Administration (FDA) for commercial use, information published by the FDA, the National Institutes of Health, the US Congress Office of Technology Assessment, and the American Academy of Pediatrics, as well as an extensive body of scientific evidence, indicate that these products are safe for the consumer. Nonetheless, it is important that consumers understand the benefits and safety of these biotechnologies. Dietitians can play an important role in providing information to consumers about the safety and benefits of bST and pST.

AB - This article reviews the literature about the safety and benefits of two recombinantly derived proteins, bovine somatotropin (bST) and porcine somatotropin (pST), that likely will be used in animal agriculture in the future. When administered to dairy cows, bST increase milk production per cow approximately 15% to 20% and improves productive efficiency approximately 10%. Administration of pST to growing pigs reduces carcass fat content by as much as 70% to 80% and improves productive efficiency 15% to 35%. Because meat is a major source of total fat and saturated fatty acids in the diets of human beings, pST will allow consumers to include leaner, more nutrient-dense pork in their diets and still meet current dietary guidelines. Although these biotechnologies have not yet received regulatory approval from the Food and Drug Administration (FDA) for commercial use, information published by the FDA, the National Institutes of Health, the US Congress Office of Technology Assessment, and the American Academy of Pediatrics, as well as an extensive body of scientific evidence, indicate that these products are safe for the consumer. Nonetheless, it is important that consumers understand the benefits and safety of these biotechnologies. Dietitians can play an important role in providing information to consumers about the safety and benefits of bST and pST.

UR - http://www.scopus.com/inward/record.url?scp=0027530420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027530420&partnerID=8YFLogxK

U2 - 10.1016/0002-8223(93)90835-9

DO - 10.1016/0002-8223(93)90835-9

M3 - Article

C2 - 8423283

AN - SCOPUS:0027530420

VL - 93

SP - 177

EP - 180

JO - Journal of the Academy of Nutrition and Dietetics

JF - Journal of the Academy of Nutrition and Dietetics

SN - 2212-2672

IS - 2

ER -